Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | HTL0039732 |
| Trade Name | |
| Synonyms | HTL-0039732|HTL 0039732 |
| Drug Descriptions |
HTL0039732 is an antagonist of the prostaglandin E2 receptor 4 (EP4), which potentially enhances anti-tumor immune response (Ann Oncol (2024) 35 (Suppl_2): S529-S530). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + HTL0039732 | Atezolizumab HTL0039732 | 0 | 1 |
| HTL0039732 | HTL0039732 | 0 | 1 |